These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23967426)

  • 21. [Study on incidence of HIV infection among heroin addicts receiving methadone maintenance treatment in Dehong prefecture, Yunnan province].
    Duan S; Yang YC; Han J; Yang SS; Yang YB; Long YC; Li GQ; Yin JS; Xiang LF; Ye RH; Gao J; Tang RH; Pang L; Rou KM; Wu ZY; He N
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Dec; 32(12):1227-31. PubMed ID: 22336606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No Increase in HIV Drug Resistance Mutations among Injecting Drug Users on Methadone Maintenance Therapy: A Prospective Cohort Study.
    Huang C; Ye L; Abdullah AS; Liang B; Jiang J; Ning C; Zang N; Zhang Y; Yang Y; Hu X; Yang Q; Luo C; Lao F; Liu H; Liang H; Huang J
    Curr HIV Res; 2020; 18(5):362-372. PubMed ID: 32652910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methadone maintenance and hepatitis C virus infection among injecting drug users.
    Crofts N; Nigro L; Oman K; Stevenson E; Sherman J
    Addiction; 1997 Aug; 92(8):999-1005. PubMed ID: 9376782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk behaviors and HIV/AIDS prevention education among IDUs in drug treatment in Shanghai.
    Zhao M; Wang QY; Lu GH; Xu P; Xu H; McCoy CB
    J Urban Health; 2005 Sep; 82(3 Suppl 4):iv84-91. PubMed ID: 16107443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methadone maintenance treatment and HIV risk-taking behaviour among injecting drug users in Berlin.
    Stark K; Müller R; Bienzle U; Guggenmoos-Holzmann I
    J Epidemiol Community Health; 1996 Oct; 50(5):534-7. PubMed ID: 8944860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug use among the urban poor in Kolkata: behaviour and environment correlates of low HIV infection.
    Panda S; Saha U; Pahari S; Nathan M; Poddar S; Neogi D; Sarkar M; Pal NK; Mahalanabis D
    Natl Med J India; 2002; 15(3):128-34. PubMed ID: 12186324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Injection drug use in Rural Iran: integrating HIV prevention into iran's rural primary health care system.
    Mojtahedzadeh V; Razani N; Malekinejad M; Vazirian M; Shoaee S; Saberi Zafarghandi MB; Hernandez AL; Mandel JS
    AIDS Behav; 2008 Jul; 12(4 Suppl):S7-12. PubMed ID: 18521737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmes.
    de la Fuente L; Bravo MJ; Toro C; Brugal MT; Barrio G; Soriano V; Vallejo F; Ballesta R;
    J Epidemiol Community Health; 2006 Jun; 60(6):537-42. PubMed ID: 16698987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus infection among a cohort of Victorian injecting drug users.
    Crofts N; Hopper JL; Bowden DS; Breschkin AM; Milner R; Locarnini SA
    Med J Aust; 1993 Aug; 159(4):237-41. PubMed ID: 7692222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with willingness to participate in a heroin prescription program among injection drug users.
    Miller CL; Strathdee SA; Kerr T; Small W; Li K; Wood E
    J Opioid Manag; 2005; 1(4):201-3. PubMed ID: 17315547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of an AIDS prevention program for methadone patients.
    Magura S; Siddiqi Q; Shapiro J; Grossman JI; Lipton DS; Marion IJ; Weisenfeld L; Amann KR; Koger J
    Int J Addict; 1991 Jun; 26(6):629-55. PubMed ID: 1757169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reaching out beyond the hills: HIV prevention among injecting drug users in Manipur, India.
    Hangzo C; Chatterjee A; Sarkar S; Zomi GT; Deb BC; Abdul-Quader AS
    Addiction; 1997 Jul; 92(7):813-20. PubMed ID: 9293040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spatial distribution of HIV, HCV, and co-infections among drug users in the southwestern border areas of China (2004-2014): a cohort study of a national methadone maintenance treatment program.
    Li M; Li R; Shen Z; Li C; Liang N; Peng Z; Huang W; He C; Zhong F; Tang X; Lan G
    BMC Public Health; 2017 Sep; 17(1):759. PubMed ID: 28962612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A study on the risk and its determinants of HIV transmission by syringe sharing among HIV-positive drug users].
    Bao Y; Zhang Y; Liang Y; Chen M; Sun J; Tan H
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Jun; 49(6):513-7. PubMed ID: 26310336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
    Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
    Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barriers and facilitators to methadone maintenance therapy use among illicit opiate injection drug users in Vancouver.
    Callon C; Wood E; Marsh D; Li K; Montaner J; Kerr T
    J Opioid Manag; 2006; 2(1):35-41. PubMed ID: 17319116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Network Location and Risk of Human Immunodeficiency Virus Transmission among Injecting Drug Users: Results of Multiple Membership Multilevel Modeling of Social Networks.
    Shahesmaeili A; Haghdoost AA; Soori H
    Addict Health; 2015; 7(1-2):1-13. PubMed ID: 26322205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV and HCV prevalence among entrants to methadone maintenance treatment clinics in China: a systematic review and meta-analysis.
    Zhuang X; Liang Y; Chow EP; Wang Y; Wilson DP; Zhang L
    BMC Infect Dis; 2012 Jun; 12():130. PubMed ID: 22682091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of HIV, HCV, and High-Risk Behaviors for Substance Users in Drop in Centers in Southern Iran.
    Salehi A; Naghshvarian M; Marzban M; Bagheri Lankarani K
    J Addict Med; 2015; 9(3):181-7. PubMed ID: 25748560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.